Professional Documents
Culture Documents
Medical
Director
Sie
Center
for
Down
Syndrome
Childrens
Hospital
Colorado,
and
CU
SOM
Associate
Professor
of
Pediatrics
Linda Crnic Institute The first global institute to encompass basic research, clinical research and clinical care specifically for people with Down syndrome.
SIE Center Serves as the clinical care center of the Linda Crnic Institute for Down Syndrome.
Global Down Syndrome Foundation The GDSF is a non-profit corporation dedicated to significantly improving the lives of people with Down syndrome by supporting basic research, clinical research and clinical care.
syndrome, not the Down syndrome person. A person with Down syndrome is not a Downs
syndrome, rather than suers from, is a vicHm of, is diseased with or aicted by
Each person has his/her own unique strengths, capabiliBes and talents. Try
not to use the clichs that are so common when describing an individual with Down syndrome. To assume all people have the same characterisHcs or abiliHes is demeaning. It reinforces the stereotype that all people with Down syndrome are the same and does not encourage opHmizaHon of abiliHes
Prevalence
Prevalence
is
rising
due
to
improved
medical
care
Improved
school
acclimaHon
and
services
that
allow
independence or maximize their abiliHes Improved understanding of potenHal for good quality of life and community acceptance/embrace Improved live expectancy to middle and late adulthood into
60s
Family strengths
Less incidence of divorce in recent studies Alignment of life values and prioriHes
Health Supervision for Children with Down Syndrome: AAP, August, 2011
These
guidelines
are
designed
to
assist
the
pediatrician
in
caring
for
the
child
with a diagnosis of Down syndrome that has been conrmed by chromosome analysis.
Although
a
pediatricians
iniHal
contact
with
the
child
is
usually
during
infancy, occasionally the pregnant woman who has been given a prenatal diagnosis of Down syndrome will be referred for review of the condiHon and the geneHc counseling provided. Therefore, this report oers guidance for this situaHon as well.
Pediatrics
2011;128:393406
Mailed
over
300
Copies
of
Guidelines
to
PCPs
Review parental concerns and chromosomal karyotype Discuss specic ndings /potenHal clinical manifestaHons Refer for geneHc counseling especially if need recurrence rate (TranslocaHon) If vomiHng or absence of stools, check for gastrointesHnal tract blockage (duodenal web or atresia, Hirschsprung disease) Echocardiogram with follow up evaluaHon by a pediatric cardiologist Exam for plethora, saturaHon for hypoxemia Review feeding history to ensure adequate caloric intake and consider feeding study MBS (This guideline was added by AAP 2011)
Marked hypotonia Slow feeding Choking with feeds Recurrent pneumonia especially RUL or other recurrent or persistent respiratory symptoms Unexplained Failure to Thrive (FTT)
AUDIOLOGY
Pass
newborn
hearing
screen
Rescreen
age
6
months
Behavioral
audiogram
(BA)
age
HEMATOLOGY
Newborn:
Obtain
CBC
More specic info provided regarding Transient MyeloproliferaHve Disorder (TMD) in guidelines Management of TMD or polycythemia per Hem-Onc specialist guidance Counsel parents of infants with TMD regarding increased risk (20%) for leukemia Need follow up with Pediatric Oncology
ENDOCRINE
Limited
changes
in
AAP
2011
update:
Primarily
more
specic
Newborn
Obtain
TSH
if
Newborn
State
Screen
(NBSS)
measures
only
FT4
Verify
NBSS
results
ConHnue
to
screen
at:
6
and
12
months
18
months
Annually
from
2
years
on
with
TSH,
T4
(sooner
if
symptoms
of
OPHTHALMOLOGY
can
be
explained
by:
Intra-cardiac
shunHng
Increased
pulmonary
blood
ow
PAH
Causes
of
PAH
include
OSA,
hypoxia,
polycythemia,
and
possible
geneHc
predisposiHon.
Keeping
these
children
appropriately
oxygenated
is
Recd
Signing
Times
Video
(English
and
Spanish)
from
library
Need
follow
up
with
family
at
medical
and
hospital
visits:
Many
at
risk
families
may
fall
thru
the
cracks
due
to
the
EI
system,
especially
if
they
move
Therapy
services:
PT,
OT-
feeding,
S/L,
case
management,
and
AIRWAY CONCERNS
First 6 months Discuss with parents symptoms of ObstrucHve Sleep Apnea (OSA) - refer for further evaluaHon if symptoms present Age 1-21 years Discuss symptoms of OSA at each WCC visit: Heavy breathing, snoring, uncommon sleep posiHons, frequent night awakening, dayHme sleepiness, apneic pauses, and behavior problems Note: A paHent with DS who snores has >95% chance of having OSA If symptoms present or abnormal sleep study - refer to physician with experHse in pediatric sleep issues and ENT Discuss obesity as risk factor for OSA Appreciate the eect of al>tude on increasing the incidence of hypoxia
ATLANTOAXIAL INSTABILITY
Monitoring
for
signs
Instruct
parents
to
contact
physician for: Change in gait or use of arms or hands Change in bowel or bladder funcHon Neck pain, sH neck, head Hlt, torHcollis or how child posiHons his/her head Change in general funcHon New weakness
Evaluation of the symptomatic child If symptoms of myelopathy present, obtain plain lateral neck radiograph in neutral posiHon only If normal: may obtain exion/extension radiographs prior to prompt referral If abnormal: no further imaging - refer ASAP to pediatric neurosurgeon or pediatric orthopedic surgeon with experHse in AAI
without DS, younger than 6 years and by older children unless under direct professional supervision
(AAP POLICY)
medical management Slow growth Unexplained FTT Anemia Abdominal pain or bloaHng Refractory developmental or behavioral problems If symptoms present, obtain simultaneous: Tissue Transglutaminase IgA (TTG) and QuanHtaHve IgA If labs abnormal: refer for subspecialty assessment If labs normal, but persistent symptoms: rrepeat tesHng Q 3 years
BEHAVIORAL SYMPTOMS
Consider communicaHon, delayed auditory funcHon, school issues If frustraHon think improper school environment Language decit oten > than cogniHve decit ADHD: EvaluaHon by same quesHonnaires as other kids [incidence the same]
ASD
regression
in
DS
occurs
at
an
average
age
of
6
years
versus
18
months
in
the
general
populaHon
AuHsm
Treatment
Network/AAP
recommendaHons
Need
yearly
assessment
in
WCC
of
social,
language,
and
socializaHon
Consider
MCHAT
yearly
unHl
6
years
old
Language
screening
most
likely
will
be
delayed
Risk-Adapted
Chemotherapy
in
Younger
Patients
With
Newly
Diagnosed
Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
study
McDowell 11
OSA can also contribute to behavior and learning issues Tonsillectomy and adenoidectomy is oten 1st line of treatment
of OSA
Need follow up sleep study since as many as 25-50% will sHll have
STUDY
compared to the general populaHon. Due to the cardiac and pulmonary co-morbidiHes faced by individuals with DS, as well as an undened predisposiHon of this populaHon to PAH.
geneHc predisposiHon.
caries-free rate (p,0.05) and lower salivary mutans streptococci counts (p,0.03) compared to their siblings. mutans streptococci in the saliva may be one of the factors contributing to the lower caries rate observed in Down syndrome
Areias 2012
What has happened since we opened Sie Center for Down Syndome ?
SCDS
IMPACT
ON
COMPLIANCE
TO
AAP/
DOWN
SYNDROME
GUIDELINES
Total
paHents=437
Referrals
for
Guidelines=379
400
350
300
250
200
150
100
50
0
165
126
379
316
244
271
Improving access, coordination and level of care for our patients Multispecialty Clinics DS ENT/sleep clinic DS Pulmonary/sleep clinic Coordination of care with subspecialists Aerodigestive Team at CHC SCDS is #1 referral source Pulmonologists 5 Cardiologists 5 GI 3 ENDO 2 Neonatologists 2 Neurologists 4 Neurosurgeons 2 35
CLINICAL
RESEARCH
Active
Comirbs
The
Sie
Center
for
Down
Syndrome
Phenotypic
Database
Population-based
study
of
incidence
of
autoimmune
diseases
in
children
with
Down
syndrome
Pain
Medication
in
Down
syndrome
during
Cardiac
Procedure;
Pharmacokinetics
and
Pharmicogenetics
Studies
awaiting
funding
A
Methyl
Donor-Rich
Diet
to
Improve
Immune
Function
and
Normalize
DNA
Methylation
in
Down
syndrome
Comirbs
in
process
Outcome
Study
of
children
with
Infantile
Spasms
Audiology
and
ENT
Issues
in
Down
Syndrome
co
morbidities
Direct
future
auto-immune
evidence
based
care
of
this population
autoimmune
disorder.
Determine
the
aect
the
Sie
Center
has
made
on
the
based care.
admissions
to
hospital
for
children
with
DS
Ater
surgery,
children
with
DS
contract
respiratory
illnesses
at
a
rate
of
3x
higher
Unknown
eect
of
possible
immune
decit
Consider
chronic
aspiraHon
if
recurrent
pneumonia
-
obtain
swallow
study
Leading
cause
of
mortality
in
published
studies
Pulm
DS
team
meeHng
regularly:5
Pulm
MDs,CNPs,fellows,RN
and
Sie
Center
CHC
needs
to
be
the
na>onal
leader
in
pulmonary/Down
syndrome
complica>ons
leading
to
protocols
and
guidelines
development Evaluate Data on Hearing tests ENT procedures Guideline compliance Sleep studies
Consider defects of neutrophil chemotaxis Children with chronic cardiac or pulmonary disease: 23-valent pneumococcal polysaccharide vaccine (PPS23) at 2 years or older
NIH
Toolbox
Assessment
of
Neurological
and
Behavioral
FuncHon
Request
for
InformaHon
(RFI)
Develop
measures
of
cognitive,
emotional,
sensory,
&
motor
health
&
function:
1)
Executive
Function
2)
Processing
Speed
3)
Learning
and
Memory
4)
Language
5)
Attention
6)
Working
Memory
SCDS
recently
contacted
to
be
involved
PAH
and
possible
cardiac
issues
OSA
can
also
contribute
to
behavior
and
learning
issues
Tonsillectomy
and
adenoidectomy
is
oten
1st
line
of
treatment
of
OSA
Need
follow
up
sleep
study
since
as
many
as
25-50%
will
sHll
have
Parental history alone does not idenHfy OSA Proposed study by Dr Halbower in DS to follow up on her
recent nding altered brain metabolites in frontal lobes normalize with OSA treatment improved neuropsych tests
Sibling Issues
Data
Set
-54
siblings
of
children
with
Down
syndrome:
Siblings
of
children
with
Down
syndrome
show
more
kindness
Siblings
participate
in
more
care
giving
activities
Refuted
previous
literature
on
gender
bias,
now
rst
SOCIAL
SKILLS,EMPATHY,IMITATION
FAMILY
EFFECTS
LOWER
DIVORCE
RATE
SIBLINGS
MORE
RESPONSIBLE,VOLUNTEER
UNIQUE
LEARNING
STRENGTHS
+VISUAL PROCESSING AND MEMORY;LTM HEART SURGERY OUTCOME IMPROVED IN DS LESS CARDIOVASCULAR DISEASE WITH AGING
SOLID TUMORS RARELY SEEN IN DS LEUKEMIA [AML] HAS IMPROVED OUTCOME MUCH LOWER INCIDENCE OF SUBSTANCE